Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 1;35(2):147-154.
doi: 10.1097/MOP.0000000000001220. Epub 2023 Jan 30.

Changing epidemiology of dengue fever in children in South America

Affiliations
Review

Changing epidemiology of dengue fever in children in South America

Silvia Nunes Szente Fonseca. Curr Opin Pediatr. .

Abstract

Purpose of review: Dengue is the most important arthropod-borne viral disease of public health significance. Its geographic distribution includes 128 countries worldwide, affecting 390 million people every year causing significant morbidity and mortality in children and adults everywhere.

Recent findings: In the past, severe dengue affected mostly adults in the Americas; this scenario has changed and now cases of dengue, severe dengue, and dengue deaths have increased in children under 15 years in Brazil and in Colombia. Dengue and COVID-19 co-infections have been reported in South America, with increased hospitalization. A dengue vaccine for 9-year-old children and older children and adults who have serological evidence of previous dengue has been licensed in many countries; a different dengue vaccine trial for 4-16-year-old children has demonstrated decrease in clinical dengue and decrease in dengue hospitalizations.

Summary: There is no specific treatment of dengue, and a changing climate, insecticide resistance and urban expansion have permitted the vector's spread, making the vector control almost impossible. The hope for dengue control relies on vaccine development; there is important research on this area with one vaccine already licensed and another one showing promising results.

PubMed Disclaimer

References

    1. da Fonseca BA, Fonseca SN. Dengue virus infections. Benedito Antonio Lopes da Fonseca, Silvia Nunes Szente Fonseca. Curr Opin Pediatr 2002; 14:67–71.
    1. Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol 2021; 78:17–32.
    1. World Health Organization. Dengue and severe dengue. WHO newsroom; [updated 10 January 2022;accessed 13 November 2022].
    1. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504–507.
    1. Pan American Organization [Internet]. Integrated management strategy for arboviral disease prevention and control in the Americas. Washington, DC [updated 2020; cited 13 November 2022]. Available at: https://iris.paho.org/bitstream/handle/10665.2/52492/9789275120491_eng.p... .

Substances